EUVIMEDEUVIMED entdecken
Crossref

New Treatments: Liraglutide

L. Gater, S. Madsbad

MD Conference Express · 2006

DOI: 10.1177/155989770600600210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MD Conference Express, 2006. Verfasst von L. Gater und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liraglutide is a long-acting analog of glucagon-like peptide-1 (GLP-1). This article discusses phase 3 trials where this agent shows promise for the treatment of type 2 diabetes.

Zitieren

APA

Gater, L., & Madsbad, S. (2006). New Treatments: Liraglutide. MD Conference Express. https://doi.org/10.1177/155989770600600210

Vancouver

Gater L, Madsbad S. New Treatments: Liraglutide. MD Conference Express. 2006. doi:10.1177/155989770600600210

BibTeX
@article{Gater2006,
  author = {Gater, L. and Madsbad, S.},
  title = {New Treatments: Liraglutide},
  journal = {MD Conference Express},
  year = {2006},
  doi = {10.1177/155989770600600210}
}
Kostenlos starten →